جست‌وجوی استاد و پژوهشگر

• Epigenetics
• MicroRNA Regulation
• Plant Stress Tolerance
• +۵ مورد دیگر

Dr. Ramanjulu Sunkar is a Regents Professor in the Department of Biochemistry & Molecular Biology at Oklahoma State University. He leads research on epigenetic and small RNA mechanisms in plant stress responses, focusing on gene regulation under drought, heat, and abiotic stresses. His work integrates genomic tools like ChIP, RNA sequencing, and CRISPR/Cas9 to study stress tolerance in crops. Education: B.Sc. (Sri Venkateswara University), M.Sc. and Ph.D. (Sri Krishnadevaraya University, India), followed by postdoctoral research at the Weizmann Institute (Israel), University of Bonn (Germany), and UC Riverside (USA). He joined Oklahoma State University in 2006, becoming Professor in 2016 and Regents Professor in 2024. Research Interests: Epigenetic modifications (DNA methylation, histone changes), microRNA-guided gene regulation, plant stress memory, and translational control mechanisms. His lab uses model systems like Arabidopsis, rice, and sorghum to study adaptive responses to environmental challenges. Grants: Over 15 grants, including USDA-funded projects on microRNA roles in photosynthesis, epigenetic control of drought tolerance, and systems genetics in rice. NSF-EPSCoR support for bioenergy research. Teaching: Courses include 'Plant Biochemistry,' 'Epigenetics,' and graduate supervision through research credits. Developed new courses on plant stress biology and molecular techniques. Labs/Teams: Leads a research group focused on epigenomics and RNA regulation in plants. Collaborates internationally on projects like the Arabidopsis transcriptome and stress memory mechanisms.

Premdass Ramdasمشاهده پروفایل

مدرس ارشد

• Cancer Cell Biology
• Quantitative Proteomics
• Genomics
• +۱۲ مورد دیگر

Dr. Premdass Ramdas is a Senior Lecturer at Monash University Malaysia, affiliated with the Jeffrey Cheah School of Medicine and Health Sciences. He joined in October 2023 with over 13 years of experience in medical biotechnology and health sciences, focusing on cancer research and bioactive natural compounds. PhD in Cancer Proteomics and Genomics, University of Malaya MSc in Medical Sciences (Cancer Genomics and Natural Products), International Medical University BSc with First-Class Honors His research focuses on the anticancer mechanisms of tocotrienols, utilizing proteomics, genomics, bioinformatics, and mouse models. He explores epigenetics, nutrigenomics, RNA/microRNA analysis, exosome biology, and AI-driven big data in cancer. His work contributes to UN Sustainable Development Goals in health and well-being. Recent publications show a strong trend in systematic reviews and mechanistic studies on vitamin E analogues in cancer, particularly colorectal and breast cancers. His research integrates molecular biology with computational approaches, including molecular docking and data mining. First-class honors for BSc Malaysian Palm Oil Board Scholarship for MSc MyBrain15 Scholarship for PhD Dr. Ramdas has secured research grants such as FRGS and actively supervises research projects. He is currently accepting PhD students and has co-supervised non-HDR reviews, indicating active mentorship. He has no known labs or teams explicitly mentioned, but collaborates extensively, particularly with Prof. Radhakrishnan A.K.

Christopher S. Sullivanمشاهده پروفایل

استاد

• Virology
• Non-coding RNA Biology
• RNA Interference
• +۵ مورد دیگر

Christopher S. Sullivan is a Professor in the Department of Molecular Biosciences within the College of Natural Sciences at the University of Texas at Austin. He directs an active research laboratory focused on viral non-coding RNA biology and host-pathogen interactions, with continuous funding evidenced by publications spanning 2005-2025. His work bridges molecular virology, immunology, and RNA biology through investigations of tumor viruses and host defense mechanisms. Research interests center on the role of non-coding RNAs in viral infection and host defense pathways, with particular emphasis on viral microRNAs , RNA interference mechanisms , and host-pathogen coevolution . His lab studies diverse virus families including Polyomaviridae, Herpesviridae, Retroviridae, and avipoxviruses, with key discoveries regarding viral miRNA functions in tumorigenesis and immune evasion. Research approaches integrate molecular virology, next-generation sequencing, and computational analysis to dissect RNA-based regulatory networks. Publications reveal consistent focus on viral non-coding RNA functions, particularly how viruses exploit host RNA machinery (notably DUSP11 phosphatase) to modulate immune responses. Recent work (2021-2025) expands into viral shedding dynamics, SARS-CoV-2 diagnostics, and circular RNA biology in polyomaviruses, demonstrating evolving yet cohesive research trajectory in RNA-virus interactions. Scientific contributions include: Pioneering identification of viral microRNAs across multiple virus families Discovery of DUSP11's critical role in RNA triphosphate regulation during infection Mechanistic insights into viral evasion of RNAi and innate immunity Development of novel RNA-based detection methods The Sullivan lab maintains active collaborations through the Center for Systems and Synthetic Biology, John Ring LaMontagne Center for Infectious Disease, and Interdisciplinary Life Sciences Graduate Programs. Lab culture emphasizes collective scientific inquiry with stated mission to 'increase understanding of pathogen-host interactions while enjoying the company of fellow lab members.' Current research directions include viral exploitation of RNA modification pathways and identification of novel host defense mechanisms using viruses as 'molecular divining rods.'

• Cybersecurity
• Digital Forensics
• AI Security
• +۶ مورد دیگر

Assoc. Prof. Nhien An Le Khac is an Associate Professor at the School of Computer Science, University College Dublin. He serves as Programme Director for the MSc in Forensic Computing & Cybercrime Investigation, which has trained over 1,500 law enforcement officers globally. His research focuses on cybersecurity, digital forensics, AI security, and secure healthcare IT systems. He holds a PhD from Institut National Polytechnique de Grenoble (France) and has supervised 9 PhD students. His work includes pioneering contributions to electromagnetic side-channel analysis (EM-SCA) for IoT forensics, blockchain forensics, and AI-based fraud detection. Education: BSc/MSc: Vietnam National University, Ho Chi Minh City PhD: Institut National Polytechnique de Grenoble, France Professional Certificate in University Teaching & Learning: UCD Research Interests: Cybersecurity, Digital Forensics, AI Security, Machine Learning, Cloud Computing, Big Data Analytics, Healthcare IT Security. Recent Article Trends: Focus on EM-SCA for IoT device forensics, illicit Bitcoin transaction tracking, and cross-device ML portability. His work bridges theoretical AI advancements with practical forensic applications, emphasizing privacy preservation and explainable AI. Awards & Recognition: World’s Top 2% Scientists (2024) UCD Teaching Excellence Awards (2022, 2018) Best Paper Awards at Elsevier, AI-2022, and DFRWS conferences Grants & Advising: Principal Investigator on grants like Cloud Atlas, CERBERUS, and Urban ARK. Advised 9 PhD students who now work in academia/research globally. Active in funding initiatives like ML-Labs (SFI-funded). Labs & Teams: Leads ASEADOS Lab and maintains datasets like EM-SCA and InSDN. Collaborates globally on forensic frameworks and cybersecurity tools.

Ralf Zimmerمشاهده پروفایل

استاد

• Bioinformatics
• Systems Biology
• Machine Learning
• +۵ مورد دیگر

Ralf Zimmer is a Full Professor for Practical Informatics and Bioinformatics at Ludwig Maximilian University of Munich (LMU) since 2001, affiliated with the Department of Informatics in the Faculty of Mathematica, Informatics and Statistics. He concurrently serves as Head of Section III and Head of the Research Group Network Regulation and Modeling / Machine Learning at the Leibniz Institute for Food Systems Biology at TUM (Leibniz-LSB@TUM) in Freising, Germany. His academic foundation includes a Diploma with distinction in Computer Science, Applied Mathematics and Operations Research from the University of Bonn (1981-1986), followed by a summa cum laude Doctorate in Computer Science and Applied Mathematics from CAU Kiel in 1990, where he received dual honors: the CAU Dissertation Award and Best Dissertation Award. Zimmer's research pioneers the integration of bioinformatics, systems biology, and machine learning to decode molecular food-consumer interactions. His group develops causal system models for biological networks, validated through in silico simulations and multi-omics perturbation experiments (transcriptomics/proteomics). Core methodologies include network regulation modeling, algorithmic bioinformatics, and database construction linking food compounds to biochemical networks and cellular phenotypes, with translational goals for food and biotech innovation. His 14 most recent publications (2012-2024) reveal dominant trends in multi-omics immunology and cardiovascular research, featuring computational innovations for high-throughput data analysis. Key themes include host-pathogen dynamics (viral infections), inflammatory disease mechanisms (atherosclerosis), and methodological advances in proteomics/transcriptomics, consistently bridging fundamental bioinformatics with clinical applications. Major scientific recognitions include: CAU Dissertation Award and Best Dissertation Award (1990) Director of LMU's Informatics Department (2010-2012) DFG Review Board membership for biomedical foundations (2008-2016) Leadership of the DFG Bioinformatics Munich Center (2001-2008) Academic Senate election at LMU München (2011) Zimmer directs LMU/TUM's joint B.Sc./M.Sc. bioinformatics programs since 2001 as founding architect of the DFG-funded Bioinformatics Munich initiative. His educational leadership spans spokesperson roles for international training groups (IRTG RECESS), collaborative research centers (SFB1123 Atherosclerosis), and elite programs (Data Science, Munich Center for Machine Learning). Grant stewardship includes directing the DFG Bioinformatics Munich Center and shaping national funding policy via the DFG review board. At Leibniz-LSB@TUM, his research group pioneers databases connecting food compounds to cellular phenotypes through molecular networks, collaborating with Munich universities, clinics, and biotech partners to develop high-throughput sequencing/proteomics applications for future food and health innovations.

• Neuroscience
• Neuroimmunology
• Epigenetics
• +۳ مورد دیگر

Anne Schaefer is a Full Professor with Tenure at the Mount Sinai School of Medicine, currently serving as Managing Director at the Max Planck Institute for Biology of Ageing in Cologne, Germany. She co-directs the Center for Glial Biology within the Friedman Brain Institute, focusing on neuroscience and psychiatry. Education: Charité University Berlin (MD/PhD), Johannes Gutenberg University Mainz (undergraduate) Research Interests: Schaefer’s work bridges neuroscience , neuroimmunology , and epigenetics , with a primary focus on microglial biology, neuronal activity regulation, and mechanisms underlying neurodegeneration. Her studies explore how microglia interact with neurons to maintain brain homeostasis and drive plasticity. Scientific Awards: Max Planck Sabbatical Award (2019) Inaugural NINDS Landis Award for Outstanding Mentorship (2018) NIH Director’s New Innovator Award (2012) Kavli Frontiers in Science Fellow (2014) German Research Foundation DFG Research Fellowship (2006–2008) Summa cum laude, Charité University Berlin (2004) Grants & Funding: Schaefer has secured significant third-party funding, including an ERC Synergy Grant (2021–2027) for the project "Micro-'COPS' - Microglia-control of physiological brain states." Labs & Teams: She leads a research team at the Max Planck Institute for Biology of Ageing and collaborates closely with the Center for Glial Biology at Mount Sinai, where she has held leadership roles since 2017.

• Artificial Intelligence in Healthcare
• Digital Health Interventions
• Chronic Disease Prevention
• +۱۵ مورد دیگر

Dr. Yoshimi Fukuoka is a Professor at the University of California, San Francisco (UCSF) School of Nursing , specializing in Physiological Nursing . She holds a PhD in Nursing and Postdoctoral Fellowship from UCSF, with a career focused on AI-driven health interventions , chronic disease prevention , and mobile health (mHealth) applications for diverse populations. Her research bridges artificial intelligence and behavioral health , emphasizing personalized physical activity programs , cardiovascular risk reduction , and diabetes prevention . She has developed AI chatbots to improve heart disease awareness and conducted clinical trials on metabolic syndrome and colorectal cancer survivorship . Recent publications highlight her work on: AI chatbots for heart attack knowledge and physical activity interventions Machine learning in diabetes risk prediction and microRNA analysis Cultural adaptations of mHealth for Asian Americans and Latinos Behavioral analytics in weight loss and exercise adherence Scientific awards include: 2014-2017: National Science Foundation EAGER Grant 2011-2013: UCSF Diabetes Family Fund Award 2010-2012: American Heart Association National Clinical Research Program Award 2008: Marie Cowan Promising Young Investigator Award Her work spans UCSF , with collaborations across NIH , Alzheimer's Association , and Noyce Foundation , addressing health disparities , digital health policy , and precision health through grants like NIH R01HL104147 and K24NR015812 . Media coverage includes USA Today , NHLBI News , and UCSF News for her AI in nursing innovations.

• Nanotechnology-based bioanalysis
• Mass spectrometry
• Lateral flow immunoassay
• +۵ مورد دیگر

Dr. Chang Lei is an ARC Discovery Early Career Researcher Award (DECRA) Fellow at the Department of Medical Sciences within the Faculty of Medicine and Health at The University of Sydney. She is also a member of The University of Sydney Nano Institute and the Charles Perkins Centre. With expertise in nanotechnology-based bioanalysis, mass spectrometry, lateral flow immunoassay, and tissue regeneration, Dr. Lei leads several innovative research projects focused on advancing healthcare through nanotechnology. Dr. Lei completed her PhD at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland (UQ). Her academic journey includes receiving the Queensland Government Advance Queensland Research Fellowship, the UQ Amplify Fellowship in 2021, and the prestigious ARC DECRA in 2024. Her research interests span across nanotechnology applications in healthcare, with particular focus on: Developing novel nanomaterials for single-cell metabolomics analysis Creating affordable and ultra-sensitive biomarker detection platforms Engineering silica bio-nanomaterials for stem cell differentiation and bone repair Advancing lateral flow immunoassay technologies using nanomaterials Applying nanotechnology to dental and craniofacial regeneration Dr. Lei's publication record demonstrates a strong focus on nanotechnology applications across multiple disciplines. Her recent work shows increasing emphasis on medical applications of nanomaterials, particularly in diagnostics, cancer therapy, and tissue regeneration. She has published in high-impact journals including Nature Science Review, Small, Biosensors and Bioelectronics, Angewandte Chemie, and Advanced Materials. Dr. Lei has received several notable awards and honors: 2024 ARC DECRA Fellow 2021 The University of Queensland Amplify Fellow 2020 GC Minimum Intervention Dentistry Research Award 2017 Advanced Queensland Research Fellow As a reviewer for scientific journals such as Science Advances, Journal of Nanobiotechnology, and Journal of Materials Chemistry B, and for ARC and NHMRC grants, Dr. Lei actively contributes to the scientific community. She also serves as an editor for Frontiers in Bioengineering and Biotechnology and Nano TransMed. Her current research projects are supported by grants including the ARC DECRA and the FMH Start-up Scheme. Dr. Lei is actively involved in several research groups and initiatives: Member of The University of Sydney Nano Institute Member of the Charles Perkins Centre Member of Australian and New Zealand Society for Mass Spectrometry Member of The Australian Materials Research Society Member of the Australian Nanotechnology Network

Adalberto Campos Fernandesمشاهده پروفایل

دانشیار

• Health Administration
• Health Management
• Health Policies
• +۴ مورد دیگر

Adalberto Campos Fernandes is an Associate Professor at the National School of Public Health (NOVA-NSPH), Universidade NOVA de Lisboa, and a researcher at the Centro de Investigação em Saúde Pública (CISP/PHRC) and Comprehensive Health Research Centre (CHRC). He holds a PhD in Health Administration from Universidade de Lisboa. Previously, he served as Minister of Health of Portugal (2015–2018) and held leadership roles in major hospitals and healthcare institutions, including the Board of Directors of Hospital de Santa Maria and Hospital Pulido Valente. Education: PhD in Health Administration (Universidade de Lisboa), Master in Public Health (ENSP-NOVA), Specialist in Public Health, and Medical Degree (Faculdade de Medicina de Lisboa). Research Focus: Health Administration, Health Management, Sustainability of Health Systems, and Public-Private Partnerships in Healthcare. His work emphasizes the integration of social and health sectors, policy analysis, and healthcare system sustainability. Recent research explores decentralized healthcare models, the impact of AI in clinical coding, and obesity management strategies. He has contributed to over 96 publications and actively participates in policy debates on healthcare accessibility and system resilience. Key roles beyond academia include serving on the Board of Directors of several hospitals and leading initiatives in public-private healthcare collaborations. His professional experience bridges academic research, policy-making, and clinical administration, shaping Portugal’s healthcare landscape.

Elvis Genbo Xuمشاهده پروفایل

دانشیار

• Environmental Pollution
• Micro/Nanoplastics
• Crude Oil Toxicology
• +۸ مورد دیگر

Elvis Genbo Xu is an Associate Professor at the Department of Biology, University of Southern Denmark. His research focuses on environmental toxicology, particularly micro/nanoplastics and crude oil pollutants. He employs transcriptomics and bioinformatics to study marine ecosystems and embryonic model systems. University of Southern Denmark Department of Biology Active since at least 2018 Research Interests: Micro/Nanoplastics Crumb Rubber Marine Protected Areas Endocrine Disruptors Transcriptomics Bioinformatics Article Trends (2018-2019): Focus on nanoplastics and microplastics Environmental impact assessment Toxicity mechanisms in aquatic organisms Methodological innovations in plastic analysis Interdisciplinary approaches combining toxicology, materials science, and molecular biology Scientific Recognition: 2024 World's Top 2% Scientists 2023 Undervisningsprisen på Naturvidenskab 2021 Faculty Research Dissemination Prize 2020 Best ES&T Letters Paper Advising & Editorial Roles: Active PhD/Postdoc supervision Junior Editor at Journal of Hazardous Materials (2020) Editorial Board member for Environment International (2022)

• Nanobiotechnology
• Biophysics
• Colloid and Interface Science
• +۴ مورد دیگر

Assoc. Prof. Dietmar Pum is a leading researcher at the Institute of Biophysics, University of Natural Resources and Life Sciences, Vienna (BOKU). With a career spanning over three decades, he has pioneered work on S-layer proteins as nanobiotechnological tools and biomimetic surface functionalization. His research bridges microbiology, biophysics, and nanomaterials science. Education & Career Doctorate (1984) and Habilitation (1992) at Vienna University of Technology Awarded FEBS (1987) and EMBO (1982) fellowships Assoc. Univ. Prof. since 1997, Deputy Head of Biophysics Institute since 2014 Research Focus Dr. Pum's work centers on leveraging S-layer proteins for nanoscale fluid mechanics , molecular imprinting , and biohybrid materials . His projects explore: Self-assembly of 2D protein crystals Functionalization of carbon nanotubes Biomimetic sensor development Applications in diagnostics and environmental technology Publication Trends His recent publications (2025-2019) highlight interdisciplinary advancements in: Nanoscale biofluid dynamics Gold nanoparticle synthesis via microbial enzymes Archaeal S-layer characterization Protein-directed nanomaterials Biosensor platforms Lipid quantification via machine learning Scientific Recognition Philip Morris Research Prize (1998) Cardinal Innitzer Prize (1992) ÖAGM Prize (1986) Peer reviewer for Nature Materials , Advanced Materials , and Biophysical Journal Advising & Collaborations Dr. Pum has supervised over 15 theses, mentoring students in topics ranging from Caenorhabditis elegans imaging to nanomembrane fabrication. He leads international collaborations under EU Horizon and FWF grants, including the Stimuli Responsive Materials project (2020-2025). Labs & Networks As a core member of BOKU's Center for NanoBiotechnology and the Ludwig Boltzmann Institute for Molecular Nanotechnology , he develops bioinspired nanomaterials and contributes to global programs in molecular self-assembly.

Andrew Godwinمشاهده پروفایل

استاد

• Molecular Oncology
• Precision Medicine
• Biomarker Discovery
• +۳ مورد دیگر

Andrew Godwin is a Professor at the University of Kansas Medical Center , where he serves as the Chancellor’s Distinguished Chair in Biomedical Sciences and Director of Molecular Oncology in the Department of Pathology and Laboratory Medicine. He is also the Deputy Director of the NCI-designated University of Kansas Cancer Center and the Founding Director of the Kansas Institute for Precision Medicine and Biospecimen Shared Resource . Dr. Godwin is a leader in translational research and precision medicine , with a focus on molecular oncology , biomarker discovery , and genomic diagnostics . His work bridges basic and clinical science to improve cancer patient care, particularly in ovarian cancer , Ewing sarcoma , and breast cancer . He has contributed over 230 ovarian cancer-related publications and pioneered studies linking the PI3K/AKT pathway to cancer treatment targets. His research program encompasses liquid biopsies using extracellular vesicles , molecular therapeutics , companion diagnostics , and clinical trial validation . He leads the Biomarker Discovery Laboratory and has secured over $250M in extramural funding , including a $11.4M NIH grant for precision medicine initiatives. His team has developed CELLSEARCH® , the first FDA-cleared test for circulating tumor cells. Notable awards include the Dolph C. Simons, Sr. Higuchi Award (2020), Outstanding Mentorship in Pathology Award (2024), and multiple mentoring accolades from KU. He has mentored over 150 trainees across career stages and leads a multidisciplinary lab with expertise in genomics , proteomics , and bioengineering . Academic Roles: Chancellor’s Distinguished Chair in Biomedical Sciences Director, Molecular Oncology, Pathology and Laboratory Medicine Deputy Director, KU Cancer Center Founding Director, Kansas Institute for Precision Medicine Adjunct Professor, Bioengineering Program, University of Kansas Scientific Awards: KUMC Achievement Award for mentoring postdocs (2014) Chancellor’s Club Award for Research (2018) Dolph C. Simons, Sr. Higuchi Award (2020) KU Excellence in Mentoring Award (2021) Outstanding Mentorship in Pathology (2024) Key Research Themes: Extracellular vesicles as liquid biopsy tools Molecular mechanisms of sarcoma and breast cancer Genomic diagnostics and precision oncology Clinical trial biomarker validation Biospecimen repository leadership

Zhishan Wangمشاهده پروفایل

استاد پژوهشی

• Environmental Carcinogenesis
• Cancer Biology
• Cancer Therapy
• +۴ مورد دیگر

Zhishan Wang, MD, PhD is a Research Professor in the Department of Pathology at Stony Brook University's Renaissance School of Medicine . His work focuses on environmental carcinogenesis , particularly mechanisms of cancer biology and cancer therapy , with a specialization in metal-induced carcinogenicity. Research Interests: Environmental Carcinogenesis Epigenetic and Epitranscriptomic Mechanisms Tumor Microenvironment Remodeling Metal Toxicity Pathobiology Non-Coding RNA Regulatory Networks Scientific Contributions: Analysis of 15 recent publications reveals expertise in: Metal-Induced Oncogenic Pathways (e.g., NF-κB activation, Hedgehog signaling) RNA Modification Dynamics (m6A, lncRNA-splicing interactions) Stem Cell Plasticity in Carcinogenesis Multi-Carcinogen Synergy Mechanisms Epigenetic-Genotoxic Interplay Transcriptomic Reprogramming by Toxicants

Yuri Pritykinمشاهده پروفایل

استادیار

• Computational Biology
• Genomics
• Machine Learning
• +۵ مورد دیگر

Yuri Pritykin is an Assistant Professor at Princeton University, affiliated with the Lewis-Sigler Institute for Integrative Genomics and the Department of Computer Science. He also holds cross-appointments in Molecular Biology, the Omenn-Darling Bioengineering Institute, and the Center for Statistics and Machine Learning. Pritykin earned his Ph.D. in Computer Science from Princeton University (2014), alongside MSc and Ph.D. in Mathematics from Lomonosov Moscow State University. His research lies at the intersection of applied statistics, machine learning, and functional genomics, focusing on integrative analysis of multi-dimensional biological data. Research Interests: Decoding regulatory genomics in immune cells, CRISPR tool development (GuideScan2), single-cell and spatial multi-omics for immunology and cancer, post-transcriptional regulation, and cell-cell interaction profiling (uLIPSTIC technology). Awards: NSF CAREER Award (2023) NIH New Innovator Award (2022) Recognized by Princeton Ludwig Institute, Rutgers Cancer Institute, and AACR Teaching: Courses in computational biology, genomics, and machine learning applications in life sciences. His lab actively collaborates with immunologists and genomicists, seeking interdisciplinary scientists at all career stages.

Allan B. Dietzمشاهده پروفایل

استاد

• Cellular Immunotherapy
• Stem Cell Biology
• Cancer Vaccines
• +۵ مورد دیگر

Allan B. Dietz is a Professor of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine and Science. He serves as Co-Director of the Human Cellular Therapy Lab at Mayo Clinic's Center for Regenerative Biotherapeutics, with dual appointments in the Department of Immunology and Division of Transfusion Medicine. 1986: BA in Biology and Chemistry from University of Northern Iowa 1992: PhD in Genetics from Texas A&M University 1993: Postdoctoral Fellowship at USDA Agricultural Research Service His research spans cellular immunotherapy, stem cell biology, and regenerative medicine , with a focus on dendritic cell vaccines for cancers (CML, melanoma, glioblastoma), monocyte immunosuppression mechanisms, and mesenchymal stromal cell applications in GVHD and tissue repair (ALS, Crohn’s, renal stenosis, diabetes). Recent work includes microfluidic bioreactor development for cell therapy manufacturing and immune profiling for cancer patients. Key publications from 2024-2025 include: Microfluidic bioreactors for dendritic cell production Pembrolizumab-ibrutinib melanoma trials Mesenchymal stem cells in spinal cord injury Multiorgan transplant immune management guidelines Awarded: 2017 Mayo Clinic Team Science Award 1997 Voyles Fellowship in Stem Cell Biology 1991 Carrington Award for Cell Biology Active in regulatory committees including FDA-compliant cell therapy oversight and ISCT North American meetings. Integrates laboratory findings with clinical workflows through Mayo Clinic's CCaTS and Center for Individualized Medicine programs.